Patent holdings for IPC class A61K 31/424

Total number of patents in this class: 414

10-year publication summary

35
31
42
34
27
36
24
23
24
10
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Merck Sharp & Dohme LLC
3741
16
F. Hoffmann-La Roche AG
7926
7
Theriva Biologics, Inc.
83
7
Novartis AG
10904
6
Hoffmann-La Roche Inc.
3379
6
Merck Sharp & Dohme Corp.
2201
6
Janssen Pharmaceutica N.V.
3423
6
Takeda Pharmaceutical Company Limited
2704
6
Constellation Pharmaceuticals, Inc.
210
6
Ovid Therapeutics Inc
154
6
Council of Scientific & Industrial Research
1421
5
Bristol-myers Squibb Company
4892
4
Genentech, Inc.
3961
4
Boehringer Ingelheim International GmbH
4704
4
Centre for Digestive Diseases
17
4
Japan Tobacco Inc.
3512
4
Otsuka Pharmaceutical Co., Ltd.
1502
4
Taisho Pharmaceutical Co., Ltd.
862
4
Amgen Inc.
4047
3
Glaxosmithkline Intellectual Property Development Limited
753
3
Other owners 303